Skip to main content
Top

06-04-2024 | Leukemia | Images

Secondary plasma cell leukaemia (PCL) with plasmablastic morphology

Authors: Ke Xu, Elisabeth Nacheva

Published in: Journal of Hematopathology

Login to get access

Abstract

A 71-year-old female with relapsed IgA lambda myeloma developed progressive cytopenia. The peripheral blood film showed 5% blastoid cells. Flow cytometry analysis was indicative of plasma cells. The bone marrow smear was packed with plasmablasts. Target CD138-cell FISH and molecular karyotyping identified a complex genome. NGS identified high-risk mutations. Bone marrow histology confirmed myeloma with no evidence of acute leukaemia. The patient was diagnosed with plasmablastic progression of myeloma and secondary PCL. Secondary PCL patients have a poor prognosis. It is essential to recognize this subtype and explore a novel treatment approach.
Literature
1.
go back to reference de Larrea CF et al (2021) Primary plasma cell leukemia: consensus definition by the Internatinoal Myeloma Working Group according to peripheral blood plasma cell percentage. Blood Cancer J 11(12):192 de Larrea CF et al (2021) Primary plasma cell leukemia: consensus definition by the Internatinoal Myeloma Working Group according to peripheral blood plasma cell percentage. Blood Cancer J 11(12):192
2.
go back to reference Jurczyszyn A et al (2019) Secondary plasma cell leukemia: a multicenter retrospective study of 101 patients. Leuk Lymphoma 60(1):118–123CrossRefPubMed Jurczyszyn A et al (2019) Secondary plasma cell leukemia: a multicenter retrospective study of 101 patients. Leuk Lymphoma 60(1):118–123CrossRefPubMed
Metadata
Title
Secondary plasma cell leukaemia (PCL) with plasmablastic morphology
Authors
Ke Xu
Elisabeth Nacheva
Publication date
06-04-2024
Publisher
Springer Berlin Heidelberg
Published in
Journal of Hematopathology
Print ISSN: 1868-9256
Electronic ISSN: 1865-5785
DOI
https://doi.org/10.1007/s12308-024-00583-w